RSV clinical trials at UCSF
3 in progress, 1 open to eligible people
RSV is a virus that causes respiratory infections in people of all ages. UCSF is studying whether azithromycin can help children with severe RSV who have respiratory failure. UCSF is also looking into how this antibiotic impacts kids' recovery from RSV in hospitals.
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
open to eligible people ages up to 2 years
The overarching hypothesis of the ARRC trial is that administration of Azithromycin (AZM) during acute, Respiratory Syncytial Virus (RSV)-induced respiratory failure will be beneficial, mediated through the matrix metalloproteinase (MMP)-9 pathway.
San Francisco, California and other locations
EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.
Sorry, in progress, not accepting new patients
This is a Phase 2b, randomized, double-blind, placebo-controlled study of EDP-938 administered orally for the treatment of non-hospitalized adult subjects with confirmed RSV infection who are at high risk for complications after RSV infection.
Fresno, California and other locations
Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection
Sorry, in progress, not accepting new patients
The goal of this clinical study is to learn more about the study drug, obeldesivir (ODV; GS-5245), and how safe and effective it is in treating nonhospitalized adults with acute respiratory syncytial virus (RSV) infection. The researchers want to see if obeldesivir can help participants' symptoms get better faster. The primary objectives of this study are to evaluate the efficacy of ODV in reducing the duration of symptoms and to evaluate the safety and tolerability of ODV in nonhospitalized adult participants with acute RSV infection.
Fresno, California and other locations
Our lead scientists for RSV research studies include Matt Zinter, MD James Howard, MD.
Last updated: